Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07CMN
|
||||
| Former ID |
DCL000590
|
||||
| Drug Name |
PD-200390
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Insomnia [ICD9: 307.41, 307.42, 327.0, 780.51, 780.52; ICD10:F51.0, G47.0] | Phase 2 | [530573] | ||
| Company |
Pfizer
|
||||
| Formula |
C25H36N2O2S
|
||||
| Canonical SMILES |
CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SCCC(=O)N(C)CCC2=CC=CC=<br />N2
|
||||
| InChI |
1S/C25H36N2O2S/c1-24(2,3)20-16-19(17-21(23(20)29)25(4,5)6)30-15-12-22(28)27(7)14-11-18-10-8-9-13-26-18/h8-10,13,16-17,29H,11-12,14-15H2,1-7H3
|
||||
| InChIKey |
YPPRSIHNTQEZCJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Voltage-dependent T-type calcium channel alpha-1G subunit | Target Info | Modulator | [549974] | |
| Pathway Interaction Database | Regulation of nuclear beta catenin signaling and target gene transcription | ||||
| PathWhiz Pathway | Muscle/Heart Contraction | ||||
| Reactome | NCAM1 interactions | ||||
| References | |||||